Church & Dwight (NYSE:CHD) recently announced a voluntary recall of several products, including Zicam Cold Remedy Nasal Swabs and Orajel Baby Teething Swabs, due to potential fungal contamination risk ...

Swabs with contamination can be a significant risk to health and safety, including life-threatening blood infections in users with compromised nasal mucosa, Church & Dwight said. The risk is highest ...

The products are being recalled due to potential microbial contamination identified as fungi in cotton swab components.

Church & Dwight recalls Zicam and Orajel swab products due to potential fungal contamination Risk of serious infection ...

Fintel reports that on June 2, 2025, RBC Capital upgraded their outlook for Church & Dwight (NYSE:CHD) from Sector Perform to ...

Key Insights Institutions' substantial holdings in Church & Dwight implies that they have significant influence ...

Church & Dwight Co., Inc. has called back all lots of Zicam nasal swabs and Orajel baby teething swabs citing potential microbial contamination, according to the U.S. Food and Drug Administration.

Investing.com -- RBC Capital Markets upgraded Church & Dwight (NYSE: CHD) to Outperform from Sector Perform and raised its ...

Analysts' ratings for Church & Dwight Co CHD over the last quarter vary from bullish to bearish, as provided by 13 analysts. The following table encapsulates their recent ratings, offering a ...

On Tuesday, 03 June 2025, Church & Dwight (NYSE:CHD) presented its strategic initiatives and financial outlook at the 2025 dbAccess Global Consumer Conference. The company emphasized its ...